![Eric Karas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Karas
Corporate Officer/Principal bei
ARS Subsidiary, Inc.
Vermögen: 73 056 $ am 31.08.2026
Profil
Eric Karas is currently Chief Commercial Officer at ARS Pharmaceuticals Operations, Inc. since 2022.
Formerly, Mr. Karas was Vice President & General Manager-Commercial at Emergent BioSolutions, Inc. from 2018 to 2022.
Mr. Karas also served as Chief Commercial Officer at ARS Pharmaceuticals, Inc. from 2022 to 2026.
Education includes an undergraduate degree from Rutgers State University of New Jersey and an MBA from Eli Broad College of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.06.2026 | 12 176 ( 0,01 % ) | 73 056 $ | 31.08.2026 |
Aktive Positionen von Eric Karas
| Unternehmen | Position | Beginn |
|---|---|---|
ARS Subsidiary, Inc.
 ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Corporate Officer/Principal | 01.04.2022 |
Ehemalige bekannte Positionen von Eric Karas
| Unternehmen | Position | Ende |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2026 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01.03.2022 |
Ausbildung von Eric Karas
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
41
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Eli Broad College of Business
 Eli Broad College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Health Technology |
ARS Pharmaceuticals, Inc.
 ARS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
